What is ADMA Biologics's net change in cash?

ADMA Biologics (ADMA) reported net change in cash of $50.52M in Q1 2026.

How has ADMA Biologics's net change in cash changed year-over-year?

ADMA Biologics's net change in cash increased by 260.3% year-over-year, from -$31.52M to $50.52M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

ADMA Biologics ADMA Net Change in Cash

Net Change in Cash at other companies

AbCellera Biologics Inc.ABCL

-$51.45M-1,849%

AnaptysBio, Inc.ANAB

$10.27M+142%

ZymeworksZYME

$203.13M+1,911%

Bio-Rad LaboratoriesBIO

-$23.2M-170%

Apogee Therapeutics, Inc.APGE

$320.25M+1,018%

Quest DiagnosticsDGX

-$27M+92.5%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's net change in cash?: ADMA Biologics (ADMA) reported net change in cash of $50.52M in Q1 2026.
How has ADMA Biologics's net change in cash changed year-over-year?: ADMA Biologics's net change in cash increased by 260.3% year-over-year, from -$31.52M to $50.52M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.